Cargando…

Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes

BACKGROUND/AIMS: Metabolic dysfunction-associated fatty liver disease (MAFLD) is categorized into three subtypes overweight/obese (OW), lean/normal weight with metabolic abnormalities, and diabetes mellitus (DM). We investigated whether fibrotic burden in liver differs across subtypes of MAFLD patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Tae Seop, Chun, Ho Soo, Kim, Soon Sun, Kim, Ja Kyung, Lee, Minjong, Cho, Hyo Jung, Kim, Seung Up, Cheong, Jae Youn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352051/ https://www.ncbi.nlm.nih.gov/pubmed/36799062 http://dx.doi.org/10.5009/gnl220400

Ejemplares similares

Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Han, Eugene, et al.
Publicado: (2022)

Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level
por: Jeon, Mi Young, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease: Definition and subtypes
por: Han, Seul Ki, et al.
Publicado: (2023)

Metabolic Dysfunction–Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study
por: Lee, Hokyou, et al.
Publicado: (2022)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
por: Yu, Jung Hwan, et al.
Publicado: (2023)

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
por: Kang, Seong Hee, et al.
Publicado: (2021)

Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease
por: Chun, Ho Soo, et al.
Publicado: (2021)

Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
por: Kim, Soon Sun, et al.
Publicado: (2022)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Han, Seul Ki, et al.
Publicado: (2023)

Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus
por: Han, Ji Eun, et al.
Publicado: (2022)

A qualitative study of self‐management experiences in people with non‐alcoholic fatty liver disease
por: Jang, Yeonsoo, et al.
Publicado: (2021)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2021)

Ideal cardiovascular health metrics and the risk of nonalcoholic fatty liver disease in Korean adults
por: Shim, Sun Young, et al.
Publicado: (2023)

Discordance between Liver Biopsy and FibroScan® in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation
por: Kim, Seung Up, et al.
Publicado: (2012)

Fibrosis Burden of Missed and Added Populations According to the New Definition of Metabolic Dysfunction-Associated Fatty Liver
por: Park, Huiyul, et al.
Publicado: (2021)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2023)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Is liver biopsy still useful in the era of non-invasive tests?
por: Lim, Tae Seop, et al.
Publicado: (2020)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
por: Han, Eugene, et al.
Publicado: (2021)

The burden of progressive fibrotic interstitial lung disease across the UK
por: Simpson, Thomas, et al.
Publicado: (2021)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Jae Seung, et al.
Publicado: (2021)

HGF and IL-10 expressing ALB::GFP reporter cells generated from iPSCs show robust anti-fibrotic property in acute fibrotic liver model
por: Choi, Ja Sung, et al.
Publicado: (2020)

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages
por: Yoon, Yongdae, et al.
Publicado: (2023)

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
por: Perumpail, Brandon J, et al.
Publicado: (2017)

Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
por: Cho, Hyo Jung, et al.
Publicado: (2019)

Self-Management and Associated Factors among Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study
por: Kwon, Oh Young, et al.
Publicado: (2022)

The Paradoxical Protective Effect of Liver Steatosis on Severity and Functional Outcome of Ischemic Stroke
por: Baik, Minyoul, et al.
Publicado: (2019)

The current trends in the health burden of primary liver cancer across the globe
por: Konyn, Peter, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature
por: Almanza, Diego, et al.
Publicado: (2018)

Fatty Liver and Insulin Resistance in the Liver-Specific Knockout Mice of Mitogen Inducible Gene-6
por: Park, Byung Kil, et al.
Publicado: (2016)

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
por: Chen, Xueying, et al.
Publicado: (2023)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Can Magnetic Resonance Elastography Fill a Niche in the Market for Noninvasive Assessment of Liver Fibrosis?
por: Kim, Seung Up
Publicado: (2017)

Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
por: Kim, Hyejin, et al.
Publicado: (2023)

Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B
por: Park, Mi Sung, et al.
Publicado: (2013)

Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study
por: Yoon, Chang-Yun, et al.
Publicado: (2017)

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
por: Kang, Seong Hee, et al.
Publicado: (2021)

Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
por: Song, Byeong Geun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ttgs1t33v9u4qkca1ghqld8q7v